FGFR2 and gastric cancer: FGFR alterations (primarily in FGFR2) are found in approximately 13% of intrahepatic cholangiocarcinomas (CCA), 3% of gallbladder cancers, 9% of gastric cancers in a Western population, and 3% of gastric cancers in an Asian population) [68–73].